Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Stagg

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Oncology (Williston Park, N.Y.)|March 1, 1988
Regional chemotherapy for colorectal cancer metastatic to the liverA P Venook, R J Stagg, B J Lewis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1985
Avoidance of gastroduodenal toxicity in patients receiving hepatic arterial 5-fluoro-2'-deoxyuridineD C Hohn, R J Stagg, D C Price, et al.
Surgery|June 1, 1986
Total hepatic arterial perfusion after occlusion of variant lobar vessels: implications for hepatic arterial chemotherapyA A Rayner, R K Kerlan, R J Stagg, et al.
Reviews of Infectious Diseases|November 1, 1984
Pharmacokinetic disposition of cefonicid in patients with renal failure and receiving hemodialysisS L Barriere, J G Gambertoglio, D P Alexander, et al.
Annals of Internal Medicine|May 1, 1984
Hepatic arterial chemotherapy for colorectal cancer metastatic to the liverR J Stagg, B J Lewis, M A Friedman, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
A preclinical and clinical overview of the nucleotide-based antiviral agent cidofovir (HPMPC)J P Lalezari, R J Stagg, H S Jaffe, et al.
Canadian Medical Association Journal|May 3, 1975
Quantitation of cell-mediated immunity: responses to dinitrochlorobenzene and ubiquitous antigensC D Thompson, S Whittingham, I R Mackay, et al.
Cancer|February 1, 1986
Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusionD C Hohn, A A Rayner, J S Economou, et al.
Cancer|June 1, 1994
A phase I/II study of alternating constant rate infusion floxuridine with constant rate infusion vinblastine for the treatment of metastatic renal cell carcinomaE J Small, J W Frye, M J Wilkinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Chemoembolization for hepatocellular carcinomaA P Venook, R J Stagg, B J Lewis, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Oncology (Williston Park, N.Y.)|March 1, 1988
Regional chemotherapy for colorectal cancer metastatic to the liverA P Venook, R J Stagg, B J Lewis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1985
Avoidance of gastroduodenal toxicity in patients receiving hepatic arterial 5-fluoro-2'-deoxyuridineD C Hohn, R J Stagg, D C Price, et al.
Surgery|June 1, 1986
Total hepatic arterial perfusion after occlusion of variant lobar vessels: implications for hepatic arterial chemotherapyA A Rayner, R K Kerlan, R J Stagg, et al.
Reviews of Infectious Diseases|November 1, 1984
Pharmacokinetic disposition of cefonicid in patients with renal failure and receiving hemodialysisS L Barriere, J G Gambertoglio, D P Alexander, et al.
Annals of Internal Medicine|May 1, 1984
Hepatic arterial chemotherapy for colorectal cancer metastatic to the liverR J Stagg, B J Lewis, M A Friedman, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
A preclinical and clinical overview of the nucleotide-based antiviral agent cidofovir (HPMPC)J P Lalezari, R J Stagg, H S Jaffe, et al.
Canadian Medical Association Journal|May 3, 1975
Quantitation of cell-mediated immunity: responses to dinitrochlorobenzene and ubiquitous antigensC D Thompson, S Whittingham, I R Mackay, et al.
Cancer|February 1, 1986
Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusionD C Hohn, A A Rayner, J S Economou, et al.
Cancer|June 1, 1994
A phase I/II study of alternating constant rate infusion floxuridine with constant rate infusion vinblastine for the treatment of metastatic renal cell carcinomaE J Small, J W Frye, M J Wilkinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Chemoembolization for hepatocellular carcinomaA P Venook, R J Stagg, B J Lewis, et al.
Pageof 2